12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

C225: Phase Ib/IIa data; Phase III

IMCL presented data from two Phase Ib/IIa trials of C225 in patients who had failed previous treatment. In the first trial, which combined C225 and cisplatin,...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >